Dr. Rupa Subramanian, MD

Dr. Subramanian practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Subramanian's NPI, 1376547174, was assigned on June 9, 2005. Dr. Subramanian graduated from Lady Hardinge Medical College in 1995. Dr. Subramanian holds California license A67026.

Dr. Subramanian's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Subramanian's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Subramanian is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Subramanian to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subramanian practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Subramanian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Subramanian is board certified in medical oncology by the American Board of Internal Medicine. Dr. Subramanian is licensed in California.

Dmand AI lists breast cancer and chronic leukemia among the conditions Dr. Subramanian treats.

CMS data shows 3,370 Medicare services from Dr. Subramanian across 12 procedure codes in 2024, for 387 Medicare patients. Medicare paid $155,282 for them. Every service was in an office.

CMS counts 387 Medicare patients who saw Dr. Subramanian in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have cancer, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subramanian's median patient age at 67, with 90% women.

In 2024, Dr. Subramanian wrote 905 Medicare Part D claims for 194 patients. 75% of them were for generic drugs. CMS names the drug for 826 of them, across 8 drugs with 11 or more claims each, at $2,171,083 in total drug cost. In 2023, CMS named 756 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Subramanian for performance year 2024, reported as part of a group. Dr. Subramanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Subramanian as offering telehealth.

Dmand AI links 3 papers to Dr. Subramanian, published from 2014 to 2015. The most frequent topics are Breast Neoplasms, High-Throughput Nucleotide Sequencing and Precision Medicine. Dr. Subramanian's most frequent co-authors are Richard Bruce Schwab, MD, Sarah Galadriel Boles, MD and Barbara A. Parker, MD.

CMS Open Payments shows 13 general payments to Dr. Subramanian from 9 drug and device companies from 2016 to 2024. Grants make up the largest share, 34% of the total. AstraZeneca Pharmaceuticals LP paid the most, $372.

Dr. Subramanian graduated from Lady Hardinge Medical College in 1995.

Dr. Subramanian is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.